Last edition
News about "therapeutic agent "
Vanda Fanapt Receives FDA Approval for Acute Treatment of Bipolar I Disorder
Vanda Pharmaceuticals Inc. has announced that the US FDA has approved Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Therapeutic Agent | 03/04/2024 | By Aishwarya | 146
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members